Economic Evaluation alongside Multinational Studies: A Systematic Review of Empirical Studies

作者: Raymond Oppong , Sue Jowett , Tracy E. Roberts

DOI: 10.1371/JOURNAL.PONE.0131949

关键词:

摘要: Purpose of the study This seeks to explore methods for conducting economic evaluations alongside multinational trials by a systematic review used in practice and challenges that are typically faced researchers who conducted evaluations. Methods A was period 2002 2012, with potentially relevant articles identified searching Medline, Embase NHS EED databases. Studies were included if they full trial. Results total 44 studies out possible 2667 met inclusion criteria. Methods analyses varied between studies, indicating lack consensus on how evaluation should be carried out. The most common challenge appeared related addressing differences countries, which hinders generalisability transferability results. Other reported inadequate sample sizes choosing cost-effectiveness thresholds. Conclusions It is recommended additional guidelines developed aid this area these based an understanding associated strengths limitations alternative approaches. Guidelines focus ensuring results will decision makers their individual countries.

参考文章(87)
Leo Marcoff, Zugui Zhang, Wei Zhang, Edward Ewen, Claudine Jurkovitz, Prisca Leguet, Paul Kolm, William S. Weintraub, Cost Effectiveness of Enoxaparin in Acute ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology. ,vol. 54, pp. 1271- 1279 ,(2009) , 10.1016/J.JACC.2009.05.060
Agota Szende, Mark Oppe, Frank de Charro, Comparative review of Time Trade-Off value sets Springer, Dordrecht. pp. 21- 28 ,(2007) , 10.1007/1-4020-5511-0_2
Florence Canoui-Poitrine, Grégoire Jeanblanc, Corinne Alberti, Priscilla Armoogum, Ana Cebrian, Didier Carrié, Patrick Henry, Emmanuel Teiger, Michel Slama, Christian Spaulding, Isabelle Durand-Zaleski, Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial. Applied Health Economics and Health Policy. ,vol. 7, pp. 19- 29 ,(2009) , 10.1007/BF03256139
George W. Torrance, Measurement of health state utilities for economic appraisal. Journal of Health Economics. ,vol. 5, pp. 1- 30 ,(1986) , 10.1016/0167-6296(86)90020-2
Fernando Antoñanzas, Transferability of economic evaluation results. PharmacoEconomics. ,vol. 22, pp. 827- 827 ,(2004) , 10.2165/00019053-200422130-00001
L. Annemans, K. Moeremans, M. Lamotte, J. Garcia Conde, H. van den Berg, H. Myint, R. Pieters, A. Uyttebroeck, Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients. Supportive Care in Cancer. ,vol. 11, pp. 249- 257 ,(2003) , 10.1007/S00520-002-0435-3
Hans-Martin Späth, Marie-Odile Carrère, Béatrice Fervers, Thierry Philip, Analysis of the eligibility of published economic evaluations for transfer to a given health care system Health Policy. ,vol. 49, pp. 161- 177 ,(1999) , 10.1016/S0168-8510(99)00057-3
Alan G Wade, José-Luis Fernández, Clément François, Karina Hansen, Natalya Danchenko, Nicolas Despiegel, Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data. PharmacoEconomics. ,vol. 26, pp. 969- 981 ,(2008) , 10.2165/00019053-200826110-00008